Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Once again PR had no effect on the stock price...

Call the company and instruct them to spend a minimum running 10-20% of the company's treasury on buying back PTSC stock through any number of approved methods. At the very least, they should spend as much buying back and retiring company stock, as they pay to themselves each and every month.

Shareholders need the priority of expensing appropriate amounts of monies that have the immediate effect of significantly enhancing Shareholder value, to be as great (greater) as the BODs immediate benefit of drawing large monthly cash paychecks.

Shareholders need to be paid too ! , and significant Share buybacks will do that !!!

1. Significantly (geometrically) increase the Share Buyback Program

2. Announce a "Tender" Offer

3. Announce a "Dutch Auction"

Share
New Message
Please login to post a reply